Qingdao Baheal Medical INC.: Announcement of China Securities Pengyuan on focusing on the share acquisition and related transactions of Qingdao Baiyang Pharmaceutical Co., Ltd.
Qingdao Baheal Medical INC.: 2023 Equity Distribution Implementation Notice
Qingdao Baheal Medical INC.: Dongxing Securities Co., Ltd. inspection opinions on the acquisition of shares and related transactions of Shanghai Baiyang Pharmaceutical Co., Ltd., Qingdao Baiyang Investment Group Co., Ltd., Qingdao Baiyang Yiren Investment Management Co., Ltd., and Beijing Baiyang Kanghe Technology Co., Ltd.
Qingdao Baheal Medical INC.: Announcement on the acquisition of shares and related transactions of Shanghai Baiyang Pharmaceutical Co., Ltd., Qingdao Baiyang Investment Group Co., Ltd., Qingdao Baiyang Yiren Investment Management Co., Ltd., and Beijing Baiyang Kanghe Technology Co., Ltd.
Baiyang Pharmaceutical: 2023 Profit Distribution Plan Announcement
Baiyang Pharmaceutical: Announcement on Intent to Sell Shares in Subsidiaries and Related Transactions
Baiyang Pharmaceutical: Announcement on the pledge of some of the shares of the controlling shareholder
Baiyang Pharmaceutical: Announcement on Proposed Sale of Shares in Holding Subsidiaries and Related Transactions
Baiyang Pharmaceutical: Announcement on the pledge of some of the shares of the controlling shareholder
Baiyang Pharmaceutical: Announcement on Proposed Sale of Shares in Holding Subsidiaries and Related Transactions
Baiyang Pharmaceutical: 2022 Equity Distribution Implementation Notice
Baiyang Pharmaceutical: 2022 Profit Distribution Plan Announcement
Baiyang Pharmaceutical: An indicative announcement on the listing and circulation of some shares issued before the initial public offering and strategic placement shares
Baiyang Pharmaceutical: Announcement on the pledge of some of the shares of the controlling shareholder
Baiyang Pharmaceutical: 2021 Profit Distribution Plan Announcement
Baiyang Pharmaceutical: Announcement on the Application for Issuance of Convertible Corporate Bonds to Unspecified Targets Accepted by the Shenzhen Stock Exchange
Baiyang Pharmaceutical: Feasibility analysis report on the use of funds raised by issuing convertible corporate bonds to unspecified targets
Baiyang Pharmaceutical: Initial Public Offering of Offline Placement of Restricted Shares, Prompt Announcement on the Listing and Circulation of Restricted Shares
Baiyang Pharmaceutical: An indicative announcement of the initial public offering of shares and listing on the GEM
Baiyang Pharmaceutical: Beijing Tianyuan Law Firm's legal opinion on the company's initial public offering of shares and listing it on the GEM of the Shenzhen Stock Exchange
No Data